
Harbor YC 申请
Harbor 在 Spring 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Spring 2026
- 行业
- Healthcare
- 团队规模
- 2
- 状态
- Active
- 已发布
- 2026
创始人
Albert CaiFounder
Nathan H. LeungFounder
Harbor 做什么
Harbor is building an AI-native contract research organization (CRO) for clinical trials. We started with an AI-native system of record for clinical trial data (electronic data capture system), grew the software business to seven trials and ~$187k in contracted software revenue over the next twelve months, then expanded into full-service trial execution and signed our first CRO contract worth $1.93M over three years. Clinical trials consume 45% of all new drug and device development spend. While some of that goes to software, sites, and patients, the largest line items are services: project management, monitoring, data management, site coordination, source verification, query resolution, record reconciliation, and analysis. Today, drug and device companies outsource clinical operations to legacy CROs and their massive teams, which is why the CRO market is $82B annually. Harbor delivers the regulated services companies buy from legacy CROs, but built around our AI-native system of record from day one. Our software already automates the core data workflows: study build, data capture, query generation, monitoring, signing, and database lock. Because we own the system of record, we can expand into the surrounding service workflows: site contracting and billing, subject engagement and retention, statistics, reporting, and more. We built Harbor because we lived through the problem. Albert spent four years in clinical trials and regulatory strategy at a medical device startup, taking an unproven wearable from first-in-human trials to FDA authorization. Nate brings the technical depth, having built scalable software at Google and Ramp and served as employee #1 at a previous YC startup.
Harbor 的 YC 申请,重建版
Y Combinator 申请
Harbor,Spring 2026 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Harbor
AI-native CRO for clinical trial operations
We are building an AI-native contract research organization product that starts with an AI-native system of record for clinical trial data. Our product automates the core data workflows like study build, data capture, query generation, monitoring, and database lock, replacing legacy CRO software and enabling us to deliver full clinical trial execution services.
We live and work in San Francisco, CA, and the company will be based there after YC.
San Francisco is where we live and has a strong healthcare and AI startup ecosystem. Being here puts us close to early customers and partners in clinical trials.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 Harbor 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 Harbor 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 Harbor 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
Harbor 是哪个 YC 批次的?
Harbor 是 Y Combinator Spring 2026 批次的成员。
谁创立了 Harbor?
Harbor 由 Albert Cai, Nathan H. Leung 创立。
Harbor 做什么?
AI-native CRO for clinical trial operations
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 Harbor 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。